Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
Lalou C, Lassarre C, Binoux M. Lalou C, et al. Endocrinology. 1996 Aug;137(8):3206-12. doi: 10.1210/endo.137.8.8754741. Endocrinology. 1996. PMID: 8754741
Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity.
Lalou C, Sawamura S, Segovia B, Ogawa Y, Binoux M. Lalou C, et al. C R Acad Sci III. 1997 Aug;320(8):621-8. doi: 10.1016/s0764-4469(97)85695-8. C R Acad Sci III. 1997. PMID: 9337997
Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3.
Lalou C, Lassarre C, Binoux M. Lalou C, et al. Horm Res. 1996;45(3-5):156-9. doi: 10.1159/000184779. Horm Res. 1996. PMID: 8964575
A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGF is a cell growth inhibitor.
Lalou C, Lassarre C, Binoux M. Lalou C, et al. Prog Growth Factor Res. 1995;6(2-4):311-6. doi: 10.1016/0955-2235(95)00040-2. Prog Growth Factor Res. 1995. PMID: 8817674
[Interactions of insulin-like growth factors (IGF) and their binding proteins with the plasminogen/plasmin activator system in cultured osteoblasts].
Lalou C, Silve C, Segovia B, Binoux M. Lalou C, et al. Ann Endocrinol (Paris). 1994;55(2):103-7. Ann Endocrinol (Paris). 1994. PMID: 7802427 French.
Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C, Silve C, Rosato R, Segovia B, Binoux M. Lalou C, et al. Endocrinology. 1994 Dec;135(6):2318-26. doi: 10.1210/endo.135.6.7527330. Endocrinology. 1994. PMID: 7527330
Protease-induced alteration of insulin-like growth factor binding protein-3 as detected by radioimmunoassay. Agreement with ligand blotting data.
Lassarre C, Lalou C, Perin L, Binoux M. Lassarre C, et al. Among authors: lalou c. Growth Regul. 1994 Jun;4(2):48-55. Growth Regul. 1994. PMID: 7524885 Clinical Trial.
Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream.
Lalou C, Binoux M. Lalou C, et al. Regul Pept. 1993 Oct 20;48(1-2):179-88. doi: 10.1016/0167-0115(93)90346-a. Regul Pept. 1993. PMID: 7505464
Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): a physiological mechanism in the regulation of IGF bioavailability.
Binoux M, Lalou C, Lassarre C, Blat C, Hossenlopp P. Binoux M, et al. Among authors: lalou c. Adv Exp Med Biol. 1993;343:293-300. doi: 10.1007/978-1-4615-2988-0_28. Adv Exp Med Biol. 1993. PMID: 7514342 Review. No abstract available.
Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.
Mazerbourg S, Zapf J, Bar RS, Brigstock DR, Lalou C, Binoux M, Monget P. Mazerbourg S, et al. Among authors: lalou c. Endocrinology. 1999 Sep;140(9):4175-84. doi: 10.1210/endo.140.9.6979. Endocrinology. 1999. PMID: 10465290
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback